Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 16, 2015 - Issue 3
Submit an article Journal homepage
319
Views
5
CrossRef citations to date
0
Altmetric
Review

Ongoing challenges for pharmacotherapy for dyslipidemia

Anthony D PisanielloUniversity of Adelaide, South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA, 5001, Australia+61 8 8128 4510; [email protected]
, MBBS,
Daniel J SchererRoyal Adelaide Hospital, Cardiovascular Investigation Unit, Adelaide, SA, Australia
, MBBS,
Yu KataokaUniversity of Adelaide, South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA, 5001, Australia+61 8 8128 4510; [email protected]
, MD &
Stephen J NichollsUniversity of Adelaide, South Australian Health and Medical Research Institute, PO Box 11060, Adelaide, SA, 5001, Australia+61 8 8128 4510; [email protected];Royal Adelaide Hospital, Cardiovascular Investigation Unit, Adelaide, SA, Australia
, MBBS PhD
Pages 347-356 | Published online: 05 Dec 2014

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Jan Lammel Lindemann & Paul Webb. (2016) Sobetirome: the past, present and questions about the future. Expert Opinion on Therapeutic Targets 20:2, pages 145-149.
Read now
Aris P Agouridis, Theodosios D Filippatos & Niki Katsiki. (2015) Current lipid-modifying agents. Expert Opinion on Pharmacotherapy 16:7, pages 1117-1118.
Read now

Articles from other publishers (3)

Ira Tabas. (2017) 2016 Russell Ross Memorial Lecture in Vascular Biology. Arteriosclerosis, Thrombosis, and Vascular Biology 37:2, pages 183-189.
Crossref
Wendy A. Teft, Bridget L. Morse, Brenda F. Leake, Aze Wilson, Sara E. Mansell, Robert A. Hegele, Richard H. Ho & Richard B. Kim. (2016) Identification and Characterization of Trimethylamine- N -oxide Uptake and Efflux Transporters . Molecular Pharmaceutics 14:1, pages 310-318.
Crossref
Thomas F. WhayneJr.Jr.. (2015) Defining the Role of PCSK9 Inhibitors in the Treatment of Hyperlipidemia. American Journal of Cardiovascular Drugs 16:2, pages 83-92.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.